<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>罕见的凝血障碍可能会使世界对Astrazeneca疫苗的希望 A rare clotting disorder may cloud the world's hopes for AstraZeneca's vaccine</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">A rare clotting disorder may cloud the world's hopes for AstraZeneca's vaccine<br/>罕见的凝血障碍可能会使世界对Astrazeneca疫苗的希望 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-03-28 05:42:08</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/3/6896be8545aadfbebabec3b92e7d6991.jpg"><img src="http://img2.diglog.com/img/2021/3/6896be8545aadfbebabec3b92e7d6991.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>In the tumultuous rollout of AstraZeneca&#39;s COVID-19 vaccine, all eyes were on the United States this week, where the company had a  highly public communication breakdown over the vaccine&#39;s efficacy with an expert panel overseeing a large study in the Americas. But on the other side of the Atlantic, the vaccine faces new concerns about safety as an explanation gains ground for the unusual strokes and clotting disorders recorded in at least 30 recipients.</p><p>在Astrazeneca＆＃39; Covid-19疫苗的动荡推出中，本周所有的眼睛都在美国，在那里，该公司在疫苗上具有高度公共沟通细分，与监督一项大型研究的专家面板的疗效进行了高度公共沟通细分在美洲。但在大西洋的另一边，疫苗面临着对安全性的新担忧，作为一个不寻常的中风和凝血障碍在至少30名接受者中记录的凝血障碍的解释。</p><p> Many European countries  suspended use of AstraZeneca’s vaccine earlier this month following initial reports of the symptoms, which have led to at least 15 deaths. Most resumed vaccinations after the European Medicines Agency (EMA)  recommended doing so on 18 March, saying the benefits of the vaccine outweigh any risks. EMA is continuing to investigate the matter and will convene a wideranging committee of experts on 29 March.</p><p> 许多欧洲国家本月早些时候暂停使用Astrazeneca的疫苗，这是症状的初始报告，这导致了至少15人死亡。欧洲药物局（EMA）后的最恢复的疫苗接种推荐在3月18日推荐，称疫苗的益处超过了任何风险。 EMA正在继续调查此事，并将在3月29日召开一名专家较大的专家委员会。</p><p>    Now, a group of researchers led by German clotting specialist Andreas Greinacher of the University of Greifswald says the highly unusual combination of symptoms—widespread blood clots and a low platelet count, sometimes with bleeding—resembles a rare side effect of the blood thinner heparin, called heparin-induced thrombocytopenia (HIT).</p><p>    现在，由德国凝血专家andreas Greenacher的一组研究人员Greifswald的Greinacher表示，症状 - 广泛的血栓和低血小板计数的高度不寻常的组合，有时患有出血 - 类似于血液稀有的肝素稀有副作用，叫肝素诱导的血小板减少症（命中）。</p><p> The scientists, who first described their findings during a 19 March press conference, recommend a way to test for and treat the disorder and say this can help ease worries about the vaccine. “We know what to do: how to diagnose it, and how to treat it,” says Greinacher, who calls the syndrome vaccine-induced prothrombotic immune thrombocytopenia, or VIPIT. Greinacher says he has submitted a manuscript to the preprint server Research Square.</p><p> 在3月19日新闻发布会上首次描述了他们的发现的科学家推荐一种方法来测试和治疗疾病并说这有助于缓解对疫苗的担忧。 “我们知道该怎么办：如何诊断它，以及如何对待它，”格林赫说，综合征疫苗诱导的普罗扑血栓形成细胞缺乏症或vipit。 Greinacher表示，他已经向预印刷服务器研究广场提交了稿件。</p><p> Even if Greinacher’s mechanism isn’t the whole story, multiple researchers told  Science they were convinced that the vaccine was causing the rare set of symptoms. If that turns out to be true, it could have major consequences for the vaccine, which is one of the cornerstones of the World Health Organization’s push to immunize the world. AstraZeneca is working with partners around the globe to make and distribute billions of doses in low- and middle-income countries, which might have a harder time identifying and treating rare side effects.</p><p> 即使格林赫赫的机制不是整个故事，多个研究人员也告诉科学，他们相信疫苗导致罕见的症状。如果这结果是真的，它可能对疫苗产生重大后果，这是世界卫生组织推动世界免疫世界的基石之一。 Astazeneca正在与全球伙伴合作，在低收入和中等收入国家进行数十亿剂，这可能会更加难以识别和治疗罕见副作用。</p><p> Europe is relying heavily on the vaccine as well; the European Union bought 400 million doses. The company&#39;s failure to deliver on time has delayed vaccine rollouts on the continent, but now, dented confidence is exacerbating the delays. And even if the risk is very low, it may make sense to use the vaccine only in those who also stand to gain the most from it: elderly people at high risk of dying from COVID-19. Several European countries have started to do this. The situation has scientists walking a tightrope: They want to make the medical profession aware of their concerns without sowing panic.</p><p> 欧洲也依赖于疫苗;欧洲联盟购买了4亿剂。公司＆＃39;未能按时交付，在大陆上推迟疫苗卷展览，但现在，凹陷的信心加剧了延误。甚至风险很低，只能在那些也可以从中获得最大的人中的那些疫苗可能有意义：从Covid-19中死亡的高风险的老年人。几个欧洲国家已经开始这样做。这种情况有科学家们走着一个绳索：他们希望让医学专业意识到他们的担忧而不会播种。</p><p> But Greinacher&#39;s hypothesis is being taken seriously. Two German medical societies put out press releases lauding him for solving the issue. In the Netherlands, the Dutch Internal Medicine Society urged internists to be aware of the symptoms and the recommended course of action. The United Kingdom has officially reported only 5 cases—despite administering 11 million doses of the AstraZeneca vaccine—but the British Society of Haematology has  urged its members to be aware of “an important and emerging area of haemostasis and thrombosis practice” and to report any possible cases. The Australian Technical Advisory Group on Immunisation has recommended against giving any COVID-19 vaccine to people with a history of HIT.</p><p> 但是Greinacher＆＃39; S假设是严重的。两家德国医学社会推出了新闻稿，赞成他解决问题。在荷兰，荷兰内科局敦促实习生意识到症状和建议的行动方案。英国已正式报告只有5例 - 尽管管理了1100万剂的阿拉西哥疫苗 - 但英国血液学学会敦促其成员意识到“一个重要和新兴地区的血清症和血栓形成的血栓形成”并报告任何可能的情况。澳大利亚免疫技术咨询小组推荐给出任何Covid-19疫苗给患有袭击史的人。 </p><p> It is not yet clear how the vaccine could trigger VIPIT, and not everyone thinks the case is closed. “It’s intriguing, but I am not entirely convinced,” says Robert Brodsky, a hematologist at Johns Hopkins University. AstraZeneca, meanwhile, has not directly responded to the reports of the rare constellation of symptoms except to say that they did not appear in any of the company’s clinical trials.</p><p>尚不清楚疫苗如何触发贵宾，而不是每个人都认为案件已关闭。 “这是有趣的，但我并不完全相信，”约翰霍普金斯大学的血液学家罗伯特布罗德斯基说。与此同时，Astrazeneca没有直接回应罕见的症状星座的报告，除了说他们没有出现在任何公司的临床试验中。</p><p> “People are absolutely working like crazy behind the scenes to provide more clarity,” says Saskia Middeldorp, a vascular internist at Radboud University Medical Center in the Netherlands, who disagreed with the temporary halt of the vaccine because she says the benefits clearly outweigh the risks.</p><p> “人们绝对工作就像疯狂的景象一样疯狂，”荷兰的拉丁德大学医疗中心的血管内科医生Saskia Middeldorp说，他不同意疫苗的临时停止，因为她说这些益处显然超过了风险的好处。</p><p>  The VIPIT story began on 27 February, when Sabine Eichinger, a hematologist at Medical University Vienna, was confronted with an unusual patient. A 49-year old nurse had sought help at a local hospital the day before, suffering from nausea and stomach discomfort, and was transferred to Eichinger’s hospital. She had a low platelet count and computed tomography scans found thromboses—blood clots—in the veins in her abdomen and later in arteries as well. “There was little we could do at this stage,” says Eichinger. The patient died the next day.</p><p>  贵宾故事于2月27日始于Sabine Eichinger，Mechance大学维也纳的血液学家面临着一个不寻常的患者。前一天，一家49岁的护士在往来一天在当地医院寻求帮助，患有恶心和胃部不适，并被转移到Eichinger医院。她的血小板计数低，计算断层扫描扫描发现血栓 - 血栓 - 在腹部和后来的动脉中。 “很少我们可以在这个阶段做，”埃希格说。患者第二天死亡。</p><p> The combination of low platelet count, or thrombocytopenia, and clots kept Eichinger thinking, however. “It’s very striking,” she says. Platelets, also known as thrombocytes, help to form blood clots, so low levels usually lead to bleeding, not clotting. “You would think that low platelets and thromboses are opposites really.” One condition where they occur together is called disseminated intravascular coagulation, when severe infection, injury, or cancer trigger clotting so widespread it uses up all the platelets, “but she had none of these things,” Eichinger says.</p><p> 然而，低血小板计数或血小板减少症的组合和凝血症保持了eichinger思维。 “这是非常引人注目的，”她说。血小板，也称为血小板，有助于形成血栓，因此低水平通常导致出血，不凝固。 “你会认为低血小板和血栓形成都是对立的。”当严重的感染，伤害或癌症触发凝血时，它们一起发生的一个条件被称为传播血管内凝血所以普遍存在的血小板，“但是她没有这些东西，”Eichinger说。</p><p> The unusual combination also appears in HIT, which can occur in patients given heparin as a drug. Heparin binds to a protein called platelet factor 4 (PF4), forming a complex. For reasons that aren&#39;t understood, some people produce antibodies against the complex, setting off an out-of-control clotting reaction. Eichinger&#39;s patient had not received heparin, but she had gotten a shot of the AstraZeneca vaccine 5 days before her symptoms began. “I thought maybe this is some kind of immune reaction,&#34; Eichinger says.</p><p> 不寻常的组合也出现在击中，其在给予肝素作为药物的患者中可能发生。肝素与蛋白质结合，称为血小板因子4（PF4），形成复合物。出于aren＆＃39; t理解的原因，有些人产生针对复合物的抗体，脱离对照的凝血反应。 eichinger＆＃39;患者没有接受肝素，但她在症状开始前5天拍摄了Astrazeneca疫苗。 “我想也许这是一种免疫反应，＆＃34; Eichinger说。</p><p> She reached out to Greinacher, who had studied HIT for decades. “Then things started happening thick and fast,” she says, as multiple countries responded to reports of clotting by suspending use of the AstraZeneca vaccine.</p><p> 她伸手去了几十年来袭击的格林赫。 “然后事情开始发生厚实，快速，”她说，由于多个国家通过暂停使用Astrazeneca疫苗来回应凝结的报道。</p><p> Greinacher says he contacted other colleagues who had studied HIT in Canada and Germany and asked the Paul Ehrlich Institute (PEI), which oversees vaccine safety in Germany, if they had seen any cases. They had. PEI recommended that Germany pause use of the vaccine as well and asked Greinacher to help investigate. He soon received blood samples from eight additional patients. All had both low platelets and unusual clotting, he says. In four samples, the researchers also found evidence for antibodies against PF4, a hallmark of HIT. He and his colleagues are now checking whether other vaccine recipients and former COVID-19 patients have similar antibodies.</p><p> Greinacher表示，他联系了在加拿大和德国袭击的其他同事，并询问保罗埃赫里希研究所（PEI），如果他们已经看到任何病例，那就监督德国的疫苗安全。他们有。 PEI建议德国暂停使用疫苗并要求Greinacher帮助调查。他很快收到了八名患者的血液样本。他说，所有人都有低血小板和不寻常的凝血。在四个样本中，研究人员还发现针对PF4的抗体，击中标志的抗体的证据。他和他的同事正在检查其他疫苗接受者和前Covid-19患者是否具有相似的抗体。 </p><p>    Brodsky says it isn’t clear whether VIPIT explains all of the cases. He agrees that the PF4 antibodies and the clotting seen in patients resemble HIT, but the link has not been proven, he says: “I’m convinced that these patients have platelet factor 4 antibodies, at least four of them. But I’m not convinced that those … antibodies are explaining the thrombocytopenia or the clotting.”</p><p>Brodsky表示，vipit是否解释了所有情况。他同意PF4抗体和患者中看到的凝血类似于击中，但链接尚未证明，他说：“我相信这些患者有血小板因子4抗体，其中至少四个。但我不相信那些......抗体正在解释血小板减少或凝血症。“</p><p>  Greinacher agrees on the need for more data. But he says it&#39;s crucial to alert doctors to the potential complication. When recognized in time, HIT can be treated with immunoglobulins—nonspecific antibodies from blood donors—that help put the brakes on platelet activation. Non-heparin blood thinners can help dissolve the clots. VIPIT should be treated in a similar way, he says. In at least one case, Greinacher says, a doctor sought the group’s advice and the patient recovered. The German Society for the Study of Thrombosis and Hemostasis, of which Greinacher is a member, has  issued a set of recommendations for diagnosing and treating VIPIT. Greinacher says he has also been in touch with safety representatives at AstraZeneca.</p><p>  Greinacher同意需要更多数据。但他说它和第39岁对潜在的并发症提醒医生至关重要。当及时识别时，可以用来自献血者的免疫球蛋白 - 非特异性抗体治疗，帮助将制动器放在血小板活化上。非肝素血液稀释剂可以帮助溶解凝块。他说，Vipit应该以类似的方式对待。在至少一个案例中，Greinacher说，医生寻求集团的建议，患者恢复。德国血栓形成和止血研究的社会，其中GreinaCher是会员，已发布一套建议，用于诊断和治疗Vipit。 Greinacher表示，他也与Astrazeneca的安全代表联系。</p><p> Nigel Key, a hematologist at the University of North Carolina at Chapel Hill, agrees on the need to alert doctors. “Maybe it is too much to expect at this point that there would be a very detailed molecular mechanism,” he says, but the advice to physicians who may encounter patients is crucial.</p><p> Nigel key是教堂山北卡罗来纳大学的血液学学家，同意了需要提醒医生的需求。 “也许在这一点上有太多的期望会有一个非常详细的分子机制，”他说，但可能遇到患者的医生的建议是至关重要的。</p><p> Brodsky and Key say the cases are striking enough that they probably represent a real side effect. “I think the vaccine is mostly safe. I think the benefits probably outweigh the risk for a general population,” Brodsky says. “But these cases raise concern that this vaccine is potentially life-threatening in a small subset of patients.”</p><p> Brodsky和Key表示案例令人震惊，以至于它们可能代表真正的副作用。 “我认为疫苗主要是安全的。我认为福利可能超过了一般人群的风险，“布罗德斯基说。 “但这些案例提高了担心这种疫苗在患者的小型子集中潜在的危及生命。”</p><p> Scientists are now scrambling to understand how big that subset is and who&#39;s in it. So far, most cases have been observed in women under 65. But that could be because of the vaccinated population: Many countries initially used AstraZeneca only in people under 65 because early clinical trials included few older recipients. That meant the vaccine was used in priority groups such as health care workers and teachers, a majority of whom are women. In Norway, for example, 78% of the AstraZeneca doses went to women, says Sara Viksmoen Watle, chief physician at the Norway Institute of Public Health. The United Kingdom, however, used the vaccine first in older people, which may explain why fewer unusual clotting events have been spotted there.</p><p> 科学家们现在争先恐后地了解哪些子集和谁在其中的副本。到目前为止，大多数病例已经在65岁以下的女性中观察到。但这可能是因为疫苗的人口：许多国家最初仅在65岁以下的人口中使用AstraZeneca，因为早期的临床试验包括少数较老的接受者。这意味着疫苗用于优先群体，如医疗保健工作者和教师，其中大多数是妇女。例如，在挪威，78％的Astrazeneca剂量向妇女参加了挪威公共卫生研究所的主任医生Sara Viksmoen Watle说。然而，英国在老年人中使用了疫苗，这可以解释为什么在那里发现了更少的异常凝血事件。</p><p> Data from Norway—whose extensive health registries make this type of research easier—suggests previous COVID-19 infection does not predispose vaccinees to a severe reaction, Watle says. Alerting clinicians will help ensure that fewer cases are missed for analysis, Key says. A global database of cases may be helpful too.</p><p> Watle说，来自挪威的挪威的挪威的数据促使这种类型的研究更容易促使疫苗接种疫苗促使疫苗。钥匙说，警报临床医生将有助于确保错过了较少的案例进行分析。全球数据库也可能有所帮助。</p><p> Many countries are, for now, accept the risk that the AstraZeneca may carry, but several have restricted its use to people who are at the highest risk of dying from COVID-19: those aged 55 or older in France, 65 or older in Sweden and Finland, and 70 or older in Iceland. That approach makes sense, says Sandra Ciesek, a virologist at Goethe University Frankfurt. “The argument I keep hearing is that the risk-benefit ratio is still positive. But we do not have just one vaccine, we have several. So restricting the AstraZeneca vaccine to older people makes sense to me, and it does not waste any doses.”</p><p> 目前，许多国家都接受了阿拉西卡卡可能携带的风险，但有些人限制了对来自Covid-19日死最高风险的人的用途：法国55岁或以上的人，瑞典65岁或以上的人和芬兰，冰岛70岁或以上。歌德大学法兰克福的病毒学家Sandra Ciesek说，这种方法有意义。 “我记入的论点是风险效益比率仍然是积极的。但我们没有一个疫苗，我们有几个。因此，将AstraZeneca疫苗限制为老年人对我有意义，它不会浪费任何剂量。“ </p><p> Denmark and Norway are waiting for more data. Norway, which has administered the AstraZeneca vaccine to 130,000 people under 65, has reported five patients who had low platelets, hemorrhage, and widespread thromboses, three of whom died. That&#39;s about one case in 25,000 vaccinees, &#34;a high number with a very critical outcome in previously healthy, young individuals,” says Watle. The country hopes to make a decision on the vaccine within 3 weeks. It can afford to hold off: COVID-19 cases are relatively low and AstraZeneca is delivering so few doses that the extended pause won&#39;t make a big difference in the short-term.</p><p>丹麦和挪威正在等待更多数据。挪威给Astrazeneca疫苗施用到65岁以下的130,000人，报告了五名血小板，出血和普遍血统血栓形成的患者，其中三名死亡。关于25,000个疫苗的大约一个案例，＆＃34;一个高位，在以前健康，年轻的个体中具有非常关键的结果，“Watle说。该国希望在3周内对疫苗作出决定。它可以承受抵押：Covid-19案例相对较低，AstraZeneca正在递送这么少的剂量，即延长的暂停赢得＆＃39; T在短期内产生了很大的差异。</p><p> Middeldorp says she expects more clarity after Monday&#39;s meeting of EMA&#39;s expert group, which includes clotting experts, neurologists, virologists, immunologists and epidemiologists. The agency says it will issue an update on the vaccine during the next meeting of its safety committee, being held from 6 to 9 April. Ideally that meeting will help clarify how frequently the condition occurs and whether the risk varies by age or sex, Middeldorp says. The world needs AstraZeneca&#39;s vaccine, she says—but that means it is crucial to fully understand its benefits and its risks.</p><p> Middeldorp说，在Monday＆＃39; Emond Group的会议上，她期望在拍摄专家，神经学家，病毒学家，免疫学家和流行病学家之后更加清晰。原子能机构表示，它将在下次安全委员会会议上发布关于疫苗的更新，从4月6日至9日举行。 Middeldorp表示，理想地，会议将有助于澄清条件发生的频率以及风险是否因年龄或性别而异。她所说，世界需要阿拉伯康哈里斯疫苗 - 但这意味着完全理解其利益及其风险至关重要。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.sciencemag.org/news/2021/03/rare-clotting-disorder-may-cloud-worlds-hopes-astrazenecas-covid-19-vaccine">https://www.sciencemag.org/news/2021/03/rare-clotting-disorder-may-cloud-worlds-hopes-astrazenecas-covid-19-vaccine</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/障碍/">#障碍</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/clotting/">#clotting</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy;2012-2021 diglog.com </div></div></body></html>